Lynparza is a pill, usually taken twice daily. It’s convenient and generally well-tolerated.
The real pressure caused by the presumed overabundance of cancer research falls on investors and decision makers who guide R&D portfolios.
What if Keytruda and Opdivo, the new lung cancer drugs, are as good as it gets? How long will it be before anyone invents medicines that are any better than what we now have?